<DOC>
	<DOCNO>NCT00728260</DOCNO>
	<brief_summary>To characterize safety profile Menactra vaccine identify signal potentially vaccine-related adverse event ( AEs ) detect pre-licensure study .</brief_summary>
	<brief_title>36-Month Post-marketing Surveillance Analysis Menactra Vaccine 2-10 Year Olds</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Receipt Menactra vaccine study period .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Meningitis</keyword>
	<keyword>Meningococcal disease</keyword>
	<keyword>Menactra vaccine</keyword>
</DOC>